3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1
2
Status
Recruiting
3
Not yet recruiting
1
Sponsor Class
INDUSTRY
3
OTHER
1
Study Type
Interventional
4
Sponsor
Cancer Type
Thoracic
4
Conditions
Small Cell Lung Carcinoma
3
Extensive Stage Small Cell Lung Cancer
1
Interventions
Carboplatin
90
pembrolizumab
73
Pemetrexed
66
Cisplatin
56
atezolizumab
31
Paclitaxel
31
Docetaxel
30
durvalumab
28
Specimen Handling
26
Nivolumab
26
Magnetic Resonance Spectroscopy
21
osimertinib
20
Gemcitabine
19
130-nm albumin-bound paclitaxel
18
Etoposide
17
Cetuximab
16
Radiotherapy
14
Platinum
13
1,2-diaminocyclohexaneplatinum II citrate
11
amivantamab
10
Taxes
10
Immunoglobulin G
10
Radiation
9
PM 01183
9
Ipilimumab
9
Disulfides
9
Bevacizumab
9
Topotecan
8
lazertinib
7
fludarabine
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
AMG 757
×
Thoracic
×
30 days
×
Clear all
NCT07637513
2026-06-09
PrE0512
PrECOG, LLC.
Phase 3
Not yet recruiting
430 enrolled
NCT07005128
2026-06-04
DeLLphi-312
Amgen
Phase 3
Recruiting
330 enrolled
NCT06598306
2026-05-29
DeLLphi-308
Amgen
Phase 1
Recruiting
220 enrolled
NCT07037758
2026-05-29
DeLLphi-311
Amgen
Phase 1
Recruiting
380 enrolled